Dyslipidemia in Type 1 Diabetes: AMaskedDanger

Area of Science:

• Endocrinology
• Metabolic Disorders
• Cardiovascular Science

Background:

• Type 1 diabetes (T1D) is associated with dyslipidemia, contributing to elevated cardiovascular (CV) disease risk.
• Quantitative lipoprotein abnormalities are observed in T1D, particularly with poor glycemic control.
• Even with optimal glycemic control, T1D patients exhibit qualitative and functional lipoprotein abnormalities.

Purpose of the Study:

• To investigate the nature of lipoprotein abnormalities in Type 1 diabetes.
• To explore the relationship between these abnormalities and cardiovascular disease risk.
• To identify potential contributing factors to dyslipidemia in T1D.

Main Methods:

• Analysis of lipoprotein profiles in Type 1 diabetes patients.
• Assessment of glycemic control and its impact on lipid parameters.
• Evaluation of lipoprotein qualitative and functional characteristics.

Main Results:

• In T1D with optimal glycemic control, triglycerides and LDL-cholesterol are normal or decreased, while HDL-cholesterol is normal or increased.
• Potentially atherogenic qualitative and functional lipoprotein abnormalities are present in T1D patients, irrespective of glycemic control.
• Recent studies report an association between these lipoprotein abnormalities and increased CV disease risk.

Conclusions:

• Type 1 diabetes patients exhibit dyslipidemia characterized by both quantitative and qualitative/functional lipoprotein abnormalities.
• These abnormalities may contribute to the heightened cardiovascular disease risk observed in T1D.
• Peripheral hyperinsulinemia, potentially due to subcutaneous insulin administration, is a likely factor in T1D dyslipidemia.